Free Trial

Teladoc Health (TDOC) Competitors

Teladoc Health logo
$6.01 +0.09 (+1.59%)
Closing price 10/13/2026 03:59 PM Eastern
Extended Trading
$6.06 +0.05 (+0.85%)
As of 07:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

Should you buy Teladoc Health stock or one of its competitors? Teladoc Health's main competitors and comparable companies include Amazon.com (AMZN), CRISPR Therapeutics (CRSP), Roku (ROKU), Zoom Communications (ZM), and American Well (AMWL). Companies are selected based on similarities in market, industry, and size.

How does Teladoc Health compare to Amazon.com?

Amazon.com (NASDAQ:AMZN) and Teladoc Health (NYSE:TDOC) are related companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Amazon.com has a net margin of 17.44% compared to Teladoc Health's net margin of -7.13%. Amazon.com's return on equity of 18.00% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Amazon.com17.44% 18.00% 8.97%
Teladoc Health -7.13%-12.15%-5.83%

In the previous week, Amazon.com had 290 more articles in the media than Teladoc Health. MarketBeat recorded 303 mentions for Amazon.com and 13 mentions for Teladoc Health. Amazon.com's average media sentiment score of 0.85 beat Teladoc Health's score of 0.78 indicating that Amazon.com is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amazon.com
166 Very Positive mention(s)
60 Positive mention(s)
44 Neutral mention(s)
26 Negative mention(s)
4 Very Negative mention(s)
Positive
Teladoc Health
5 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Amazon.com presently has a consensus target price of $322.53, suggesting a potential upside of 24.73%. Teladoc Health has a consensus target price of $7.54, suggesting a potential upside of 25.30%. Given Teladoc Health's higher probable upside, analysts plainly believe Teladoc Health is more favorable than Amazon.com.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amazon.com
0 Sell rating(s)
3 Hold rating(s)
56 Buy rating(s)
0 Strong Buy rating(s)
2.95
Teladoc Health
1 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.25

Amazon.com has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market.

Amazon.com has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amazon.com$716.92B3.89$77.67B$12.4320.80
Teladoc Health$2.53B0.43-$200.32M-$0.99N/A

72.2% of Amazon.com shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 8.9% of Amazon.com shares are owned by company insiders. Comparatively, 0.7% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Amazon.com beats Teladoc Health on 13 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to CRISPR Therapeutics?

Teladoc Health (NYSE:TDOC) and CRISPR Therapeutics (NASDAQ:CRSP) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Teladoc Health presently has a consensus price target of $7.54, indicating a potential upside of 25.30%. CRISPR Therapeutics has a consensus price target of $67.50, indicating a potential upside of 34.73%. Given CRISPR Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe CRISPR Therapeutics is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.25
CRISPR Therapeutics
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
2.68

Teladoc Health has higher revenue and earnings than CRISPR Therapeutics. CRISPR Therapeutics is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.43-$200.32M-$0.99N/A
CRISPR Therapeutics$3.51M1,380.11-$581.60M-$4.76N/A

In the previous week, CRISPR Therapeutics had 1 more articles in the media than Teladoc Health. MarketBeat recorded 14 mentions for CRISPR Therapeutics and 13 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.78 beat CRISPR Therapeutics' score of 0.35 indicating that Teladoc Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
5 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CRISPR Therapeutics
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Teladoc Health has a net margin of -7.13% compared to CRISPR Therapeutics' net margin of -3,368.72%. Teladoc Health's return on equity of -12.15% beat CRISPR Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-7.13% -12.15% -5.83%
CRISPR Therapeutics -3,368.72%-24.39%-18.25%

Teladoc Health has a beta of 2.14, suggesting that its share price is 114% more volatile than the broader market. Comparatively, CRISPR Therapeutics has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market.

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 69.2% of CRISPR Therapeutics shares are held by institutional investors. 0.7% of Teladoc Health shares are held by company insiders. Comparatively, 5.2% of CRISPR Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Teladoc Health beats CRISPR Therapeutics on 9 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to Roku?

Teladoc Health (NYSE:TDOC) and Roku (NASDAQ:ROKU) are related companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

Roku has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Roku, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.43-$200.32M-$0.99N/A
Roku$4.74B4.78$88.36M$2.3465.24

Teladoc Health has a beta of 2.14, indicating that its stock price is 114% more volatile than the broader market. Comparatively, Roku has a beta of 2.05, indicating that its stock price is 105% more volatile than the broader market.

In the previous week, Teladoc Health had 1 more articles in the media than Roku. MarketBeat recorded 13 mentions for Teladoc Health and 12 mentions for Roku. Teladoc Health's average media sentiment score of 0.78 beat Roku's score of 0.72 indicating that Teladoc Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
5 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Roku
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 86.3% of Roku shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Comparatively, 13.5% of Roku shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Roku has a net margin of 6.82% compared to Teladoc Health's net margin of -7.13%. Roku's return on equity of 13.73% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-7.13% -12.15% -5.83%
Roku 6.82%13.73%8.34%

Teladoc Health currently has a consensus target price of $7.54, suggesting a potential upside of 25.30%. Roku has a consensus target price of $156.17, suggesting a potential upside of 2.30%. Given Teladoc Health's higher probable upside, equities research analysts clearly believe Teladoc Health is more favorable than Roku.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.25
Roku
0 Sell rating(s)
19 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.33

Summary

Roku beats Teladoc Health on 13 of the 17 factors compared between the two stocks.

How does Teladoc Health compare to Zoom Communications?

Zoom Communications (NASDAQ:ZM) and Teladoc Health (NYSE:TDOC) are related companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

In the previous week, Zoom Communications had 6 more articles in the media than Teladoc Health. MarketBeat recorded 19 mentions for Zoom Communications and 13 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.78 beat Zoom Communications' score of 0.53 indicating that Teladoc Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zoom Communications
8 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teladoc Health
5 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Zoom Communications has a net margin of 65.19% compared to Teladoc Health's net margin of -7.13%. Zoom Communications' return on equity of 10.86% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Zoom Communications65.19% 10.86% 8.93%
Teladoc Health -7.13%-12.15%-5.83%

Zoom Communications currently has a consensus price target of $113.62, indicating a potential upside of 15.75%. Teladoc Health has a consensus price target of $7.54, indicating a potential upside of 25.30%. Given Teladoc Health's higher possible upside, analysts plainly believe Teladoc Health is more favorable than Zoom Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zoom Communications
0 Sell rating(s)
11 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.56
Teladoc Health
1 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.25

Zoom Communications has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.14, meaning that its share price is 114% more volatile than the broader market.

66.5% of Zoom Communications shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 8.8% of Zoom Communications shares are held by company insiders. Comparatively, 0.7% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Zoom Communications has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Zoom Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zoom Communications$4.87B5.88$1.90B$10.809.09
Teladoc Health$2.53B0.43-$200.32M-$0.99N/A

Summary

Zoom Communications beats Teladoc Health on 12 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to American Well?

Teladoc Health (NYSE:TDOC) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

American Well has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.43-$200.32M-$0.99N/A
American Well$249.32M0.81-$95.70M-$4.77N/A

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 12.8% of American Well shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Teladoc Health had 8 more articles in the media than American Well. MarketBeat recorded 13 mentions for Teladoc Health and 5 mentions for American Well. American Well's average media sentiment score of 1.08 beat Teladoc Health's score of 0.78 indicating that American Well is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
5 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
American Well
2 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Teladoc Health has a beta of 2.14, suggesting that its share price is 114% more volatile than the broader market. Comparatively, American Well has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

Teladoc Health has a net margin of -7.13% compared to American Well's net margin of -35.75%. Teladoc Health's return on equity of -12.15% beat American Well's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-7.13% -12.15% -5.83%
American Well -35.75%-30.12%-22.30%

Teladoc Health presently has a consensus target price of $7.54, suggesting a potential upside of 25.30%. American Well has a consensus target price of $9.50, suggesting a potential downside of 22.18%. Given Teladoc Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Teladoc Health is more favorable than American Well.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.25
American Well
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Teladoc Health beats American Well on 11 of the 16 factors compared between the two stocks.

Get Teladoc Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TDOC vs. The Competition

MetricTeladoc HealthHealthcare Technology IndustryHealthcare SectorNYSE Exchange
Market Cap$1.08B$1.88B$7.27B$23.13B
Dividend YieldN/A3.94%2.52%3.72%
P/E Ratio-6.0718.10202.9022.99
Price / Sales0.4393.51561.4821.54
Price / Cash3.2932.1377.1637.05
Price / Book0.776.0510.614.73
Net Income-$200.32M-$19.09M$3.50B$1.07B
7 Day Performance8.46%-0.62%-2.89%0.52%
1 Month Performance-7.59%-2.20%-7.37%-3.15%
1 Year Performance-32.54%-20.67%3.00%6.80%

Teladoc Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TDOC
Teladoc Health
2.9938 of 5 stars
$6.01
+1.6%
$7.54
+25.3%
-27.1%$1.08B$2.53BN/A5,600
AMZN
Amazon.com
4.8996 of 5 stars
$259.53
-1.1%
$322.53
+24.3%
+17.5%$2.80T$775.68B20.881,576,000
CRSP
CRISPR Therapeutics
3.4561 of 5 stars
$51.55
-3.4%
$67.94
+31.8%
-26.6%$4.98B$11MN/A393
ROKU
Roku
2.2486 of 5 stars
$152.81
0.0%
$156.17
+2.2%
+62.7%$22.68B$5.21B65.303,600
ZM
Zoom Communications
4.1638 of 5 stars
$97.94
+0.2%
$113.62
+16.0%
+24.0%$28.58B$4.99B9.077,438

Related Companies and Tools


This page (NYSE:TDOC) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners